skip to main content
Refinado por: assunto: Leukopenia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC

Chen, Bo ; Wu, Jian‐Xiong ; Cheng, Shu‐Hui ; Wang, Li‐Ming ; Rong, Wei‐Qi ; Wu, Fan ; Wang, Shu‐Lian ; Jin, Jing ; Liu, Yue‐Ping ; Song, Yong‐Wen ; Ren, Hua ; Fang, Hui ; Tang, Yuan ; Li, Ning ; Li, Ye‐Xiong ; Wang, Wei‐Hu

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2595-2604 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

2
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial

Tang, Ling-Long ; Guo, Rui ; Zhang, Ning ; Deng, Bin ; Chen, Lei ; Cheng, Zhi-Bin ; Huang, Jing ; Hu, Wei-Han ; Huang, Shao Hui ; Luo, Wei-Jun ; Liang, Jin-Hui ; Zheng, Yu-Ming ; Zhang, Fan ; Mao, Yan-Ping ; Li, Wen-Fei ; Zhou, Guan-Qun ; Liu, Xu ; Chen, Yu-Pei ; Xu, Cheng ; Lin, Li ; Liu, Qing ; Du, Xiao-Jing ; Zhang, Yuan ; Sun, Ying ; Ma, Jun

JAMA : the journal of the American Medical Association, 2022-08, Vol.328 (8), p.728-736 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

3
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Material Type:
Artigo
Adicionar ao Meu Espaço

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Zhong, Wen-Zhao ; Wang, Qun ; Mao, Wei-Min ; Xu, Song-Tao ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Yan, Hong-Hong ; Yang, Xue-Ning ; Zhou, Qing ; Wu, Yi-Long ; Wu, Yi-Long ; Wang, Qun ; Mao, Wei-Min ; Wu, Lin ; Shen, Yi ; Liu, Yong-Yu ; Chen, Chun ; Cheng, Ying ; Xu, Lin ; Wang, Jun ; Fei, Ke ; Li, Xiao-Fei ; Li, Jian ; Huang, Cheng ; Liu, Zhi-Dong ; Xu, Shun ; Chen, Ke-Neng ; Xu, Shi-Dong ; Liu, Lun-Xu ; Yu, Ping ; Wang, Bu-Hai ; Ma, Hai-Tao ; Wang, Si-Yu ; Hu, Jian ; Liu, Wei ; Li, Wei ; Shi, Jian-Hua

The lancet oncology, 2018-01, Vol.19 (1), p.139-148 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

4
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Xu, Binghe ; Zhang, Qingyuan ; Zhang, Pin ; Hu, Xichun ; Li, Wei ; Tong, Zhongsheng ; Sun, Tao ; Teng, Yuee ; Wu, Xinhong ; Ouyang, Quchang ; Yan, Xi ; Cheng, Jing ; Liu, Qiang ; Feng, Jifeng ; Wang, Xiaojia ; Yin, Yongmei ; Shi, Yanxia ; Pan, Yueyin ; Wang, Yongsheng ; Xie, Weimin ; Yan, Min ; Liu, Yunjiang ; Yan, Ping ; Wu, Fei ; Zhu, Xiaoyu ; Zou, Jianjun

Nature medicine, 2021-11, Vol.27 (11), p.1904-1909 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

5
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Zhang, Pin ; Zhang, Qingyuan ; Tong, Zhongsheng ; Sun, Tao ; Li, Wei ; Ouyang, Quchang ; Hu, Xichun ; Cheng, Ying ; Yan, Min ; Pan, Yueyin ; Teng, Yuee ; Yan, Xi ; Wang, Ying ; Xie, Weimin ; Zeng, Xiaohua ; Wang, Xiaojia ; Hu, Changlu ; Geng, Cuizhi ; Zhang, Hongwei ; Li, Wenxin ; Wu, Xinhong ; Zhong, Jincai ; Xu, Jingwei ; Shi, Yanxia ; Wei, Wenhua ; Bayaxi, Nayima ; Zhu, Xiaoyu ; Xu, Binghe

The lancet oncology, 2023-06, Vol.24 (6), p.646-657 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

6
Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study
Material Type:
Artigo
Adicionar ao Meu Espaço

Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study

Du, Yingying ; Cao, Qisheng ; Jiang, Congqiao ; Liang, Hui ; Ning, Zhongliang ; Ji, Chushu ; Wang, Jinguo ; Zhou, Chaoping ; Jiang, Zonghui ; Yu, Changjun ; Li, Lei ; Zhao, Yong ; Xu, Yuemei ; Xu, Tengyun ; Hu, Wenjun ; Wang, Daoqin ; Cheng, Huaidong ; Wang, Guihe ; Zhou, Jinhua ; Wang, Song ; Zhang, Yanshun ; Hu, Zhiqiang ; Li, Xinzhong ; Lu, Donghui ; Zhang, Jun ; Xie, Hua ; Sun, Guoping

Cancer medicine (Malden, MA), 2020-07, Vol.9 (14), p.5008-5014 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

7
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4
Material Type:
Artigo
Adicionar ao Meu Espaço

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4

Xu, Binghe ; Hu, Xichun ; Li, Wei ; Sun, Tao ; Shen, Kunwei ; Wang, Shusen ; Cheng, Ying ; Zhang, Qingyuan ; Cui, Shude ; Tong, Zhongsheng ; Geng, Cuizhi ; Song, Erwei ; Huang, Chiun-Sheng ; Sriuranpong, Virote ; Ngan, Roger K.C. ; Chia, Yee H. ; Wang, Xinwei ; Zhao, Huadong

European journal of cancer (1990), 2022-11, Vol.175, p.236-245 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

8
Management of Complex Infections in Hemophagocytic Lymphohistiocytosis in Adults
Material Type:
Artigo
Adicionar ao Meu Espaço

Management of Complex Infections in Hemophagocytic Lymphohistiocytosis in Adults

Zhang, Yi ; Cheng, Zhipeng ; Hu, Yu ; Tang, Liang V

Microorganisms (Basel), 2023-06, Vol.11 (7), p.1694 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

9
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
Material Type:
Artigo
Adicionar ao Meu Espaço

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Zhang, Qing Yuan ; Sun, Tao ; Yin, Yong Mei ; Li, Hui Ping ; Yan, Min ; Tong, Zhong Sheng ; Oppermann, Christina P. ; Liu, Yun Peng ; Costa, Romulo ; Li, Man ; Cheng, Ying ; Ouyang, Qu Chang ; Chen, Xi ; Liao, Ning ; Wu, Xin Hong ; Wang, Xiao Jia ; Feng, Ji Feng ; Hegg, Roberto ; Kanakasetty, G.B. ; Coccia-Portugal, Maria A. ; Han, Ru Bing ; Lu, Yi ; Chi, Hai Dong ; Jiang, Ze Fei ; Hu, Xi Chun

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920963925-1758835920963925 [Periódico revisado por pares]

London, England: SAGE Publications

Texto completo disponível

10
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Liu, Xu ; Zhang, Yuan ; Yang, Kun-Yu ; Zhang, Ning ; Jin, Feng ; Zou, Guo-Rong ; Zhu, Xiao-Dong ; Xie, Fang-Yun ; Liang, Xiao-Yu ; Li, Wen-Fei ; He, Zhen-Yu ; Chen, Nian-Yong ; Hu, Wei-Han ; Wu, Hai-Jun ; Shi, Mei ; Zhou, Guan-Qun ; Mao, Yan-Ping ; Guo, Rui ; Sun, Rui ; Huang, Jing ; Liang, Shao-Qiang ; Wu, Wei-Li ; Su, Zhen ; Li, Ling ; Ai, Ping ; He, Yu-Xiang ; Zang, Jian ; Chen, Lei ; Lin, Li ; Huang, Shao Hui ; Xu, Cheng ; Lv, Jia-Wei ; Li, Ying-Qing ; Hong, Shu-Bin ; Jie, Yu-Sheng ; Li, Hao ; Huang, Sai-Wei ; Liang, Ye-Lin ; Wang, Ya-Qin ; Peng, Ying-Lin ; Zhu, Jin-Han ; Zang, Sheng-Bing ; Liu, Song-Ran ; Lin, Qing-Guang ; Li, Hao-Jiang ; Tian, Li ; Liu, Li-Zhi ; Zhao, Hong-Yun ; Lin, Ai-Hua ; Li, Ji-Bin ; Liu, Na ; Tang, Ling-Long ; Chen, Yu-Pei ; Sun, Ying ; Ma, Jun

The Lancet (British edition), 2024-06, Vol.403 (10445), p.2720-2731 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
  1. Antes de2016  (1)
  2. 2016Até2017  (2)
  3. 2018Até2019  (2)
  4. 2020Até2021  (4)
  5. Após 2021  (7)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.